If you've ever been told you don't meet POTS criteria, even though you have all the symptoms, you already know how this goes. You waited months for the tilt table test. You stood there feeling terrible, watching your vision narrow and your thoughts scatter. And the report came back saying your heart rate didn't rise enough. Not 30 beats per minute. Not POTS. No diagnosis. No direction.
For most people in the early stages of trying to figure out what's going on, the main thing you're looking for is what do I have? Tell me the name, so I know where to go next. You search, and you see symptoms that line up. But you do the testing, and you don't quite fit in the box. That can send you into a spiral of frustration with the doctors, frustration with the process, frustration with your own body for not cooperating with a test that was supposed to give you answers.
This article is about why that box was the wrong shape to begin with.
Where the 30 Beat Per Minute Number Actually Came From
The threshold that determines whether you get a POTS diagnosis or not, 30 beats per minute of heart rate increase on standing, did not emerge from studying people with POTS. It came from two small studies conducted before POTS was even named.
In 1987, Dr. David Streeten published a book called Orthostatic Disorders of the Circulation. In it, he reported data from 92 healthy participants, mainly physicians, nurses, secretaries, and laboratory technicians. He had them stand for three minutes (not the ten minutes most POTS definitions use today) and measured their heart rate change. The 97.5 percentile landed at 27 beats per minute. He suggested that 28 or higher should be considered abnormal.
Six years later, in 1993, Drs. Schondorf and Low published what's considered the first formal description of POTS. Their control group? Twenty men and twenty-one women. Forty-one people total. They were tilted for two to three minutes. The threshold they calculated was 31 beats per minute for women and 37.9 beats per minute for men.
From those two studies, separated by six years, with a combined participant pool smaller than a high school classroom, the 30 BPM number was born. Somewhere between Streeten's 28 and Low's 31, the field landed on 30 as the cutoff. And it stuck.
"There's nothing special about 30 beats per minute other than the fact that we had these two studies done in a six-year period in the late '80s, early '90s, where they kind of arrived at 30, plus or minus 10."
Here's what makes it worse. When Low's group repeated the analysis in 1997 with a much larger sample of 557 people, the 97.5 percentile for young adults was actually between 34 and 40 beats per minute, not 30. Their own data showed the threshold should have been higher. But 30 had already entered the literature. It was already being used in clinical criteria. And so the number that defines whether you get a diagnosis or get sent home is an artifact from the late 1980s that even the researchers who popularized it found to be imprecise.
Figure: The 30 BPM POTS threshold traces back to small studies on healthy medical staff, not dysautonomia patients
The Canadian Cardiovascular Society went a step further in their 2020 position statement. They proposed that adults must reach a minimum standing heart rate of 90 BPM, and teenagers 100 BPM, for a POTS diagnosis. Meaning that someone whose heart rate goes from a resting 55 to a standing 84 (a 29-beat change) would not qualify for POTS under any current criteria. Whether that person feels terrible, can't think straight, and can barely stand long enough to cook dinner is not part of the equation.
What POTS and OCHOS Actually Share
Dysautonomia is a general term for conditions where the autonomic system isn't working correctly. POTS fits into that category. But it isn't the only thing in there. Orthostatic cerebral hypoperfusion syndrome (OCHOS) is another, defined by Dr. Peter Novak at Harvard's Brigham and Women's Hospital in 2016.
Both conditions share the same core failure: the brain isn't getting enough blood flow when you're upright. The reflexes that should kick in, the automations that are supposed to protect cerebral perfusion during that transition from laying down to standing, aren't working correctly.
When we measure cerebral blood flow with transcranial Doppler during a tilt test, we're looking for the brain to maintain at least 90% of its resting blood flow within the first minute of standing. By minute two, we don't want it dropping below 85%. In both POTS and OCHOS, that's where the failure happens. Blood flow to the brain drops below those thresholds, and the symptoms start: the fog, the dizziness, the lightheadedness, the feeling like the world is closing in.
The difference between the two labels? Whether your heart rate rises enough to cross an arbitrary line.
Why Your Body Picks One Response Over the Other
If cerebral blood flow drops in both conditions, why does one person's heart rate spike and another's doesn't? This is where the conversation gets interesting, because the answer has very little to do with the severity of the problem and everything to do with the body's available toolkit for responding to it.
Think about what happens when blood flow to the brain drops. The body detects this (ideally), and it has a few options for trying to fix it. One of those options is to crank up the heart rate. Push more blood per minute. That's the POTS response. But here's the thing that most people don't realize: as heart rate goes up, the amount of blood pumped per beat (stroke volume) actually starts to decrease past a certain point. The heart fills less completely when it beats faster. So there's a sweet spot of cardiac efficiency, a heart rate zone where you're getting the maximum blood output. Below that zone, you're not pushing hard enough. Above it, you're spinning the engine fast but moving less blood with each beat.
Where that sweet spot lands depends on who you are. Your cardiovascular conditioning. Whether you were a runner or a weightlifter or a software engineer. Whether you've been deconditioned for six months or six years. The starting state of your system determines which tools are available and how efficiently they can be deployed.
Figure: The same cerebral blood flow problem leads to a POTS diagnosis or no diagnosis at all, depending on heart rate compensation
Someone who starts with a resting heart rate of 60 and goes to 90 on standing is experiencing a very different physiological situation than someone who starts at 90 and goes to 110, even though both have the same 20-beat change. And both are different from someone starting at 100 who goes to 120. None of them cross the 30 BPM threshold. All three would be sent home without a diagnosis under current criteria. But each of those starting heart rates is telling a completely different story about the body's baseline state and its capacity to respond.
Someone whose resting heart rate is already at 100 is telling you that the system is already running hot just to maintain blood flow at rest. There's probably more of that internal vibration, more of that sense of anxiety at baseline, more unease even when laying down. Their body doesn't have much room to ramp up further. Someone resting at 60 has a different reserve, different efficiency, and their system might be choosing a more conservative compensation strategy. Both have cerebral hypoperfusion. Both feel awful. But the 30 BPM number only sees one dimension of a multidimensional problem.
The Labels Are Fluid, Not Fixed
This is the part that rarely gets discussed: you can move between these categories over time. As the body deconditions, the heart can lose some of its compensatory capacity. Someone who initially presented with a big tachycardic response might, after months or years of illness, show a smaller one. Their heart rate no longer hits that 30 BPM threshold. By the current diagnostic framework, they would technically stop qualifying for POTS, even though they feel worse than they did at the start.
This is the pattern people see after protocols like the CHOP exercise program. You build some cardiac efficiency. Maybe your heart rate doesn't spike as dramatically. But you still feel terrible because the underlying cerebral blood flow problem hasn't been addressed. You've trained the heart to be slightly more efficient, but the brain still isn't getting what it needs. The symptom set barely moves.
"You can get a stronger heart, but not necessarily have a better outcome in this situation. The label changes. The problem doesn't."
Think about that from the patient's perspective. You've been exercising, doing everything right by the current treatment playbook. Your heart rate numbers improve on the tilt test. Your cardiologist says you're getting better. But you still can't stand in the grocery store without feeling like you're going to collapse. The measurements that are improving aren't the measurements that matter.
What Actually Matters: Cerebral Blood Flow
In Novak's defining 2016 study, OCHOs patients showed a mean cerebral blood flow velocity drop of 24.1% during tilt, while controls barely moved at 4.2%. Blood pressure and heart rate? Nearly identical between the two groups. A clinician staring at the tilt table monitor would call the OCHOs test completely normal and send the patient home.
Van Campen and colleagues at the Stichting CardioZorg in the Netherlands took this further. In a study of 429 ME/CFS patients, 82% of those with normal heart rate and blood pressure responses still showed abnormal cerebral blood flow reductions during tilt. Even people who would have passed a standard autonomic test with flying colors were losing significant brain perfusion. The symptoms correlated linearly with the degree of blood flow drop, not with heart rate, not with blood pressure.
The only way to see this is with transcranial Doppler ultrasound running during the tilt. It measures blood flow velocity in the middle cerebral artery in real time, beat by beat, as the body transitions from supine to upright. Without it, you're watching two numbers (heart rate and blood pressure) that can both look perfect while the brain quietly loses its fuel supply.
Figure: Standard testing misses cerebral hypoperfusion entirely. TCD reveals the actual problem.
The Diagnostic Gap No One Talks About
The clinical reality right now is that most people cannot get an OCHOS diagnosis. Not because the science doesn't support it, but because the equipment isn't there. Most autonomic labs don't run transcranial Doppler during tilt. They have the arm cuff, the heart rate monitor, maybe a respiratory belt. That's it.
Without TCD, the only diagnostic tool available is the 30 BPM threshold. If you cross it, you're in. If you don't, you're out. And that number, as we've established, was derived from studies on healthy medical staff in the 1980s and '90s, with sample sizes under 100 and test durations of two to three minutes.
In Novak's second screening study of 744 patients, he identified 97 patients with OCHOS. Not one of them had been previously diagnosed. Every single one had gone through conventional autonomic testing and been told they were normal. The tests they had were technically correct. They just weren't measuring the right thing.
This means that for the majority of people dealing with dysautonomia right now, whether you get any help at all depends on whether your heart rate crosses a threshold that even the people who set it have acknowledged is imprecise. If you're on one side, you get a label, a community, a treatment path. If you're on the other side, you get told it might be anxiety.
What This Means For You
POTS and OCHOS probably don't deserve to be two different labels. If we're really paying attention, they both tell the same story: cerebral perfusion isn't being maintained on standing. How the body tries to compensate for that, whether it cranks the heart rate or doesn't, tells you something about the body's toolkit. It doesn't tell you that you have two different diseases.
What matters is getting adequate testing. Testing that actually looks at cerebral blood flow, because it's the thing that's going to allow you to get quality of care that moves beyond symptom management into treating the mechanism that's actually driving this. We pair transcranial Doppler with capnography, vestibular evaluation, and comprehensive autonomic testing, because knowing that blood flow drops is only half the answer. You need to know why it drops.
Most people dealing with dysautonomia are relatively young. This shouldn't be a lifetime event. Systematically moving through the problem, identifying the specific mechanism, measuring whether interventions are actually changing it, that's how you solve it rather than just managing it.
Get Your POTS & Dysautonomia Roadmap
A free guide to understanding what's actually happening in your brain, and what to do about it.
Get the Free Roadmap
Sources
- Streeten DHP. (1987). Orthostatic Disorders of the Circulation: Mechanisms, Manifestations, and Treatment. Plenum Press.
- Schondorf R, Low PA. (1993). "Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia?" Neurology, 43(1), 132-137. PubMed
- Low PA et al. (1997). "Postural tachycardia syndrome (POTS)." Neurology, 45(4 Suppl 5), S19-S25.
- Novak P. (2016). "Orthostatic Cerebral Hypoperfusion Syndrome." Frontiers in Aging Neuroscience, 8:22. PubMed
- van Campen CLMC, Rowe PC, Visser FC. (2020). "Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia." Clinical Neurophysiology Practice, 5, 69-75. PMC
- Sheldon RS et al. (2020). "Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance." Canadian Journal of Cardiology, 36(3), 357-372. PubMed
- Khan MS, Miller AJ, Ejaz A et al. (2025). "Cerebral Blood Flow in Orthostatic Intolerance." Journal of the American Heart Association. JAHA